Cairo Pharmaceuticals (CPCI.CA) Central Auditing Organization Report
Company Name : Cairo Pharmaceuticals
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content :
Central Auditing Organization Report on the financial statements for the financial period ending 31/12/2024.
Corporate Governance Report (1,947 KB)
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content :
Central Auditing Organization Report on the financial statements for the financial period ending 31/12/2024.
Corporate Governance Report (1,947 KB)
Comments